1.The Effect of Zoledronic Acid on the Volume of the Fusion-Mass in Lumbar Spinal Fusion.
Ye Soo PARK ; Hong Sik KIM ; Seung Wook BAEK ; Dong Yi KONG ; Jeong Ah RYU
Clinics in Orthopedic Surgery 2013;5(4):292-297
BACKGROUND: Few studies have explored the effects of bisphosphonates on bony healing in patients undergoing spinal fusion surgery. Most previous studies used animal models and found that bisphosphonate shows negative effects on spinal fusion consolidation. We intended to evaluate the effect of a single-dose of zoledronic acid on the volume of the fusion-mass in lumbar spinal fusion. METHODS: A retrospective review was carried out on 44 patients with symptomatic degenerative lumbar spinal stenosis who underwent one or two-level posterolateral fusion from January 2008 and January 2011. They were divided into 4 groups: group 1, autograft and zoledronic acid; group 2, allograft and zoledronic acid; group 3, autograft alone; and group 4, allograft alone. Functional radiography and three-dimensional computed tomography scans were used to evaluate and quantify the volume of the fusion-mass. The visual analog scale (VAS), the Oswestry disability index (ODI), and the short form 36 (SF-36) were used to evaluate the clinical outcomes. RESULTS: The mean volume of the fusion-mass per level was 8,814 mm3, 8,035 mm3, 8,383 mm3, and 7,550 mm3 in groups 1, 2, 3, and 4, respectively, but there were no significant differences between the groups (p = 0.829). There were no significant decreases in the volume of the fusion-mass (p = 0.533) in the zoledronic acid groups (groups 1 and 2). The VAS, the ODI, and the SF-36 at the 6-month follow-up after surgery were not significantly different (p > 0.05) among the 4 groups. The VAS, the ODI, and the SF-36 were not correlated with the volume of the fusion-mass (p = 0.120, 0.609, 0.642). CONCLUSIONS: A single dose of zoledronic acid does not decrease the volume of the fusion-mass in patients undergoing spinal fusion with osteoporosis. Therefore, we recommend that zoledronic acid may be used after spinal fusion in osteoporotic patients.
Aged
;
Aged, 80 and over
;
Bone Density Conservation Agents/*therapeutic use
;
Diphosphonates/*therapeutic use
;
Female
;
Humans
;
Imidazoles/*therapeutic use
;
Lumbar Vertebrae/drug effects/pathology/radiography/surgery
;
Male
;
Middle Aged
;
Osteoporosis/drug therapy
;
Pain Measurement
;
Pain, Postoperative
;
Quality of Life
;
Retrospective Studies
;
Spinal Fusion/adverse effects/*methods
;
Spinal Stenosis/pathology/radiography/*surgery
;
Treatment Outcome
2.A Case of Epidural Abscess Occurred after Liver Abscess Complicated by Transarterial Chemoembolization in a Patient with Metastatic Cancer to Liver.
Yong Jae LEE ; Gwang Ha KIM ; Do Youn PARK ; Suk KIM ; Chang Jun PARK ; Tae Kyun KIM ; Jung Hee KOH
The Korean Journal of Gastroenterology 2013;61(4):225-229
Transarterial chemoembolization (TACE) is one of the most effective therapies for unresectable hepatocelluar carcinoma or metastatic hypervascular tumors. Abscess occurring in the other organs beside the liver after TACE is a complication that often occurs, sometimes potentially fatal. We report a case of spinal epidural abscess occurred after liver abscess complicated by TACE in a patient with metastatic neuroendocrine tumors to the liver. A 67-year-old female underwent TACE first for the metastatic lesions to liver, with a history of pancreatoduodenectomy for the primary pancreatic neuroendocrine tumor. Four days after TACE, sudden high fever occurred, and liver abscess was found on abdominal CT. Two days later, back pain and radiating pain to the right leg occurred, and lumbar spine MRI showed spinal epidural abscess. After intravenous antibiotics for 8 weeks and partial laminectomy, the patient recovered and was discharged without complications.
Aged
;
Anti-Bacterial Agents/therapeutic use
;
Carcinoma, Hepatocellular/secondary/*therapy
;
Chemoembolization, Therapeutic/*adverse effects
;
Epidural Abscess/*etiology/microbiology/surgery
;
Escherichia coli/isolation & purification
;
Escherichia coli Infections/drug therapy
;
Female
;
Humans
;
Laminectomy
;
Liver Abscess/*etiology
;
Liver Neoplasms/secondary/*therapy
;
Lumbar Vertebrae/microbiology/radiography
;
Magnetic Resonance Imaging
;
Neuroendocrine Tumors/pathology/surgery
;
Pancreaticoduodenectomy
;
Tomography, X-Ray Computed